SEARCH

SEARCH BY CITATION

References

  • 1
    Moscona A. Neuraminidase Inhibitors for Influenza. N Engl J Med 2005; 353:13631373.
  • 2
    Jain S, Kamimoto L, Bramley AM et al. 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med 2009; 361:135144.
  • 3
    Kohno S, Kida H, Mizuguchi M, Shimada J, S-021812 Clinical Study Group. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Antimicrob Agents Chemother 2010; 54:45684574.
  • 4
    Hernandez JE, Adiga R, Armstrong R et al. Clinical experience in adults and children treated with intravenous Peramivir for 2009 influenza A (H1N1) Under an emergency IND program in the United States. Clin Infect Dis 2011; 52:695706.
  • 5
    Watanabe A, Chang SC, Kim MJ, Chu DW, Ohashi Y, MARVEL Study Group. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial. Clin Infect Dis 2010; 51:11671175.
  • 6
    Sugaya N, Ohashi Y. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrob Agents Chemother 2010; 54:25752582.